As of 2024-12-13, the Relative Valuation of Exact Sciences Corp (EXAS) is (34.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 62.51 USD, the upside of Exact Sciences Corp based on Relative Valuation is -155.2%.
The range of the Relative Valuation is (28.10) - (36.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 31.1x | 26.4x |
| Forward P/E multiples | 24.3x - 42.1x | 33.2x |
| Fair Price | (28.10) - (36.01) | (34.52) |
| Upside | -145.0% - -157.6% | -155.2% |
| Date | P/E |
| 2024-12-12 | -54.05 |
| 2024-12-11 | -54.61 |
| 2024-12-10 | -53.25 |
| 2024-12-09 | -53.44 |
| 2024-12-06 | -54.01 |
| 2024-12-05 | -54.14 |
| 2024-12-04 | -55.46 |
| 2024-12-03 | -52.37 |
| 2024-12-02 | -53.34 |
| 2024-11-29 | -53.68 |
| 2024-11-27 | -53.34 |
| 2024-11-26 | -51.97 |
| 2024-11-25 | -47.68 |
| 2024-11-22 | -45.75 |
| 2024-11-21 | -45.89 |
| 2024-11-20 | -45.57 |
| 2024-11-19 | -46.62 |
| 2024-11-18 | -42.84 |
| 2024-11-15 | -42.66 |
| 2024-11-14 | -44.04 |
| 2024-11-13 | -43.87 |
| 2024-11-12 | -43.37 |
| 2024-11-11 | -44.39 |
| 2024-11-08 | -44.52 |
| 2024-11-07 | -46.03 |
| 2024-11-06 | -47.32 |
| 2024-11-05 | -61.84 |
| 2024-11-04 | -61.51 |
| 2024-11-01 | -60.36 |
| 2024-10-31 | -59.60 |
| 2024-10-30 | -60.93 |
| 2024-10-29 | -60.22 |
| 2024-10-28 | -59.97 |
| 2024-10-25 | -59.76 |
| 2024-10-24 | -60.75 |
| 2024-10-23 | -60.76 |
| 2024-10-22 | -61.03 |
| 2024-10-21 | -60.08 |
| 2024-10-18 | -62.20 |
| 2024-10-17 | -59.86 |
| 2024-10-16 | -61.07 |
| 2024-10-15 | -60.49 |
| 2024-10-14 | -61.30 |
| 2024-10-11 | -61.36 |
| 2024-10-10 | -59.96 |
| 2024-10-09 | -59.25 |
| 2024-10-08 | -59.29 |
| 2024-10-07 | -59.88 |
| 2024-10-04 | -59.11 |
| 2024-10-03 | -57.43 |